Jacob D. Jaffe

Jacob D. Jaffe

Auto-generated profile, based on publicly available information

Jacob D. Jaffe

Broad Institute of MIT and Harvard, Cambridge, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2019 in Science
Verified
Journal Article
Closed access
PDF file
ACAbhishek A. Chakraborty
Abhishek A. Chakraborty
TLTuomas Laukka
Tuomas Laukka
MMMatti Myllykoski
Matti Myllykoski
ARAlison . Ringel
Alison . Ringel
MBMatthew A. Booker
Matthew A. Booker
WKWilliam G. Kaelin
William G. Kaelin
Oxygen sensing revisited: The cellular response to hypoxia (oxygen deficiency) is a contributing factor in many human diseases. Previous studies examining the way in which hypoxia alters gene expression have focused on oxygen-sensing enzymes that regulate the activity of a transcription factor called hypoxia-inducible factor (see the Perspective by Gallipoli and Huntly). Chakraborty et al. and Batie et al. now show that hypoxia can also affect gene expression through direct effects on chromatin regulators. Certain histone demethylases, such as KDM6A and KDM5A, were found to be direct sensors of oxygen. In cell-culture models, hypoxia diminished the activity of these enzymes and caused changes in the expression of genes that govern cell fate. Science , this issue p. 1217 , p. 1222 ; see also p. 1148

1 March 2019 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
KKKarsten Krug
Karsten Krug
PMPhilipp Mertins
Philipp Mertins
BZBin Zhang
Bin Zhang
PHPeter Hornbeck
Peter Hornbeck
RRRajesh Raju
Rajesh Raju
DMD. R. Mani
D. R. Mani
Signaling pathways are orchestrated by post-translational modifications (PTMs) such as phosphorylation. However, pathway analysis of PTM datasets generated by mass spectrometry (MS)-based proteomics is typically performed at a gene-centric level due to the lack of appropriately curated PTM signature databases and bioinformatic tools that leverage PTM site-specific information. Here we present the first version of PTMsigDB, a database of modification site-specific signatures of perturbations, kinase activities and signaling pathways curated from more than 2,500 publications. We adapted the widely used single sample Gene Set Enrichment Analysis approach to utilize PTMsigDB, enabling PTM Signature Enrichment Analysis (PTM-SEA) of quantitative MS data. We used a well-characterized dataset of epidermal growth factor (EGF)-perturbed cancer cells to evaluate our approach and demonstrated better representation of signaling events compared to gene-centric methods. We then applied PTM-SEA to analyze the phosphoproteomes of cancer cells treated with cell-cycle inhibitors and detected mechanism-of-action specific signatures of cell cycle kinases. We also applied our methods to analyze the phosphoproteomes of PI3K-inhibited human breast cancer cells and detected signatures of compounds inhibiting PI3K as well as targets downstream of PI3K (AKT, MAPK/ERK) covering a substantial fraction of the PI3K pathway. PTMsigDB and PTM-SEA can be freely accessed at https://github.com/broadinstitute/ssGSEA2.0.

5 May 2021 in Nature
Verified
Journal Article
Closed access
PDF file
GGGabriel K. Griffin
Gabriel K. Griffin
JWJingyi Wu
Jingyi Wu
AIArvin Iracheta-Vellve
Arvin Iracheta-Vellve
JPJames C. Patti
James C. Patti
JHJeffrey Hsu
Jeffrey Hsu
BBBradley E. Bernstein
Bradley E. Bernstein

22 February 2018 in Blood
Verified
Journal Article
Open access
PDF file
SHSteven M. Horwitz
Steven M. Horwitz
RKRaphael Koch
Raphael Koch
PPPierluigi Porcu
Pierluigi Porcu
YOYasuhiro Oki
Yasuhiro Oki
AMAlison Moskowitz
Alison Moskowitz
DWDavid M. Weinstock
David M. Weinstock
Key Points: The oral PI3K-δ,γ inhibitor duvelisib demonstrated clinical activity and a favorable safety profile in patients with CTCL and PTCL. Duvelisib induced cell-autonomous killing of TCL lines and reprogrammed PTCL-associated macrophages in vivo.

28 January 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JPJohn R. Prensner
John R. Prensner
OEOana M. Enache
Oana M. Enache
VLVictor Luria
Victor Luria
KKKarsten Krug
Karsten Krug
KCKarl R. Clauser
Karl R. Clauser
TGTodd R. Golub
Todd R. Golub

3 October 2012 in Genome Biology
Verified
Journal Article
Open access
PDF file
MKManching Ku
Manching Ku
JJJacob D Jaffe
Jacob D Jaffe
RKRichard P Koche
Richard P Koche
EREsther Rheinbay
Esther Rheinbay
MEMitsuhiro Endoh
Mitsuhiro Endoh
BBBradley E Bernstein
Bradley E Bernstein
Background: The histone variant H2A.Z has been implicated in nucleosome exchange, transcriptional activation and Polycomb repression. However, the relationships among these seemingly disparate functions remain obscure. Results: We mapped H2A.Z genome-wide in mammalian ES cells and neural progenitors. H2A.Z is deposited promiscuously at promoters and enhancers, and correlates strongly with H3K4 methylation. Accordingly, H2A.Z is present at poised promoters with bivalent chromatin and at active promoters with H3K4 methylation, but is absent from stably repressed promoters that are specifically enriched for H3K27 trimethylation. We also characterized post-translational modification states of H2A.Z, including a novel species dually-modified by ubiquitination and acetylation that is enriched at bivalent chromatin. Conclusions: Our findings associate H2A.Z with functionally distinct genomic elements, and suggest that post-translational modifications may reconcile its contrasting locations and roles.